Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Impax Laboratories, Inc., a specialty pharmaceutical company, announced that the US Food and Drug Administration (FDA) has approved its generic version of glyburide tablets 1.25 mg, 2.5 mg, and 5 mg. The company is preparing for commercialisation of this product through Impax's generic division.

  • Nestle India on asked the apex consumer court why fresh tests were being ordered on Maggi noodles on food safety when a similar exercise has already been conducted as per directions of the Bombay High Court.

  • In a bid to ensure that children left out of routine immunization drive get vaccinated, the union health ministry launched the second part of Mission Indradhanush, its flagship vaccination programme.

  • Researchers have designed and synthesised a nanometer-scale DNA "machine" that can make the process of detecting the antibodies that can help with the diagnosis of infectious and auto-immune diseases such as rheumatoid arthritis and HIV much cheaper.

  • A new research suggests that replacing sitting desks with sit-stand desks at offices could offer a cost-effective and sustainable approach to fight  obesity. The study was published in the American Journal of Preventive Medicine.

  • While exercise is good for everyone, it is also a well known fact that some struggle more than others, suggested a recent study by researchers at Lund University. The researchers studied the effects of exercise in people with increased risk of type 2 diabetes caused by being immediately related to someone with the disease. The study is published in Journal of Applied Physiology.

  • Allergan plc,, a leading global pharmaceutical company, has received approval from the US Food and Drug Administration (FDA) to market Juvederm Ultra XC for injection into the lips and perioral area for lip augmentation in adults over the age of 21.

Subscribe to Pharma News